Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141175 |
| CAS No | NA |
| Mol.F. | C15H19N7O3 |
| Mol.Wt. | 345.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141176 |
| CAS No | NA |
| Mol.F. | C16H12BrN7O3 |
| Mol.Wt. | 430.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141177 |
| CAS No | NA |
| Mol.F. | C16H13N7O3 |
| Mol.Wt. | 351.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141178 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141179 |
| CAS No | NA |
| Mol.F. | C24H25N9O3 |
| Mol.Wt. | 487.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141180 |
| CAS No | NA |
| Mol.F. | C30H35N9O5 |
| Mol.Wt. | 601.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141181 |
| CAS No | NA |
| Mol.F. | C18H29N3O2 |
| Mol.Wt. | 319.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141182 |
| CAS No | 36966-84-4 |
| Mol.F. | C6H6N2O |
| Mol.Wt. | 122.1 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141183 |
| CAS No | NA |
| Mol.F. | C9H14N2OS |
| Mol.Wt. | 198.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141184 |
| CAS No | 70890-80-1 |
| Mol.F. | C2H2N4O2 |
| Mol.Wt. | 114.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141185 |
| CAS No | NA |
| Mol.F. | C15H9ClN4O4 |
| Mol.Wt. | 344.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141186 |
| CAS No | NA |
| Mol.F. | C18H16N2O3 |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141187 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141188 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141189 |
| CAS No | NA |
| Mol.F. | C14H11N3O3 |
| Mol.Wt. | 269.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141190 |
| CAS No | NA |
| Mol.F. | C14H10N4O5 |
| Mol.Wt. | 314.3 |
| INV STATUS | CUSTOM SYNTHESIS |